|
2024
|
Invention
|
Nuclear transport modulators and uses thereof.
The present invention relates to compounds of for... |
|
|
Invention
|
Selinexor and analogs for use in the treament of endometrial cancer in patients with wild-type tp... |
|
2023
|
Invention
|
Nuclear transport modulators and uses thereof.
The invention generally relates to nuclear transp... |
|
|
Invention
|
Crystalline forms of eltanexor and process for preparing same. The invention relates to a crystal... |
|
|
Invention
|
Hydrazide containing nuclear transport modulators and uses thereof. The invention generally relat... |
|
|
Invention
|
Polymorphs of selinexor.
The present invention relates to crystalline forms of the compound repr... |
|
|
Invention
|
Polymorphs of selinexor. The present invention relates to crystalline forms of the compound repre... |
|
2022
|
Invention
|
Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms.
T... |
|
|
Invention
|
Methods of synthesis of heteroaryl derivatives of triazolyl acrylamides and crystalline forms. Th... |
|
|
Invention
|
Calb1 biomarker in the treatment of de-differentiated liposarcoma using xpo1 inhibitors, such as ... |
|
|
Invention
|
Biomarkers for response to exportin-1 inhibitors in multiple myeloma patients. A method of treati... |
|
2021
|
Invention
|
Crystalline form of selinexor.
The invention relates to a crystalline form of the compound repre... |
|
|
Invention
|
Crystalline form of selinexor. The invention relates to a crystalline form of the compound repres... |
|
|
Invention
|
Co-crystal forms of selinexor.
The present invention is directed to selinexor co-crystal forms; ... |
|
|
Invention
|
Nuclear transport modulators and uses thereof. The present invention relates to compounds of form... |
|
|
P/S
|
Pharmaceuticals for treatment of cancer |
|
|
P/S
|
Pharmaceuticals. |
|
|
P/S
|
Pharmaceuticals for treatment of cancer. |
|
|
Invention
|
Il-12 compositions and methods of use in hematopoietic recovery.
Aspects and embodiments of the ... |
|
|
P/S
|
pharmaceuticals for treatment of life threatening diseases; pharmaceuticals for treatment of cancer |
|
|
Invention
|
Xpo1 inhibitors for use in treating cancer. A method of treating a AML in a subject in need there... |
|
|
Invention
|
Biomarkers for response to exportin-1 inhibitors in multiple myeloma patients. A computer-impleme... |
|
|
Invention
|
Biomarkers for response to exportin-1 inhibitors in diffuse large b-cell lymphoma patients. A com... |
|
|
P/S
|
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation, inflammator... |
|
|
P/S
|
Pharmaceuticals, namely, drugs for the treatment of cancer,
inflammation and other diseases rela... |
|
|
Invention
|
Treatment of covid-19 with a sine compound. The disclosure relates to a method of treating COVID-... |
|
|
Invention
|
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof.
The invention generally re... |
|
|
Invention
|
Nuclear transport modulators and uses thereof. Compounds of formula I:
and pharmaceutically acc... |
|
|
Invention
|
Xpo1 inhibitors for use in treating cancer. A method of treating a glioblastoma in a subject in n... |
|
2020
|
P/S
|
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammation and other di... |
|
|
P/S
|
Providing financial assistance to eligible beneficiaries, through third parties, in the form of c... |
|
|
P/S
|
Providing financial assistance to eligible beneficiaries,
through third parties, in the form of ... |
|
|
Invention
|
Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xpo1 inhibi... |
|
|
Invention
|
Process for preparing xpo1 inhibitors and intermediates for use in the preparation of xp01 inhibi... |
|
|
Invention
|
Biomarkers for selinexor.
A method of treating a patient suffering from multiple myeloma, compri... |
|
|
Invention
|
Biomarkers for selinexor. A method of treating a patient suffering from multiple myeloma, compris... |
|
2019
|
Invention
|
E2f1 as a biomarker for treatments using xpo1 inhibitors. The invention generally relates to the ... |
|
|
Invention
|
The combination of xpo1 inhibitors and second agents for the treatment of prostate cancer.
This ... |
|
|
Invention
|
The combination of xpo1 inhibitors and second agents for the treatment of prostate cancer. This i... |
|
|
Invention
|
Substituted benzofuranyl and benzoxazolyl compounds and uses thereof. The invention generally rel... |
|
2018
|
P/S
|
Pharmaceutical preparations, namely, drugs for the treatment of cancer, inflammatory muscle and c... |
|
|
P/S
|
Pharmaceutical preparations, namely, drugs for the treatment
of cancer, inflammation and other d... |
|
2017
|
P/S
|
Pharmaceutical preparations, namely, drugs for the treatment of cancer |
|
|
Invention
|
Crm1 inhibitors for treating epilepsy. The invention generally relates to the use of nuclear tran... |
|
|
Invention
|
Uses of il-12 as a replacement immunotherapeutic.
Aspects and embodiments of the present disclos... |
|
2016
|
Invention
|
3-(pyridin-3-yl)-acrylamide and n-(pyridin-3-yl)-acrylamide derivatives and their use as pak or n... |
|
2015
|
P/S
|
Providing an internet website portal in the field of pharmaceutical research that allows for user... |
|
2013
|
P/S
|
Pharmaceuticals, namely, drugs for the treatment of cancer [ , inflammation ] and [ other ] disea... |
|
|
P/S
|
Pharmaceuticals, namely, drugs for the treatment of cancer ((, inflammation and other diseases re... |
|
|
P/S
|
Pharmaceuticals, namely, drugs for the treatment of cancer [ ((, inflammation] and [ other ] dis... |
